First Western Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
First Western Capital Management's GILD Position: Q1 2018 in Review
First Western Capital Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 37,548 shares — an estimated $2.69M sold.
First Western Capital Management first reported a position in GILD in Q4 2013 and held it in 17 quarters. The position peaked at $8.4M in Q3 2014. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.
- First Western Capital Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
- First Western Capital Management sold 37,548 Gilead Sciences shares in Q1 2018, an estimated $2.69M.
- First Western Capital Management first reported a position in Gilead Sciences in Q4 2013 and held it in 17 quarters.
- First Western Capital Management's Gilead Sciences position peaked at $8.4M in Q3 2014.
- 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.
Based on First Western Capital Management's 13F filing for Q1 2018, filed 14 May 2018.